The consortium found that variation in NAT2 was associated with insulin resistance although this did not reach formal genome-wide significance (rs1208 was associated with decreased insulin sensitivity with p = 9.81 × 10−7 after adjusting for BMI). This evidence concerns the gene INS and Insulin resistance.